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INTRODUCTION
Dermatomyositis is an idiopathic inflammatory myo-
pathy with characteristic skin manifestations. Although
the disorder is rare, with a prevalence of one to 10 cases
per million in adults and one to 3.2 cases per million in
children, early recognition and treatment are important
ways to decrease the morbidity of systemic compli-
cations.1
In 1975, Bohan and Peter first suggested a set of criteria
to aid in the diagnosis and classification of derma-
tomyositis and polymyositis (PM). Four of the 5 criteria
are related to the muscle disease, as follows:
progressive proximal symmetrical weakness, elevated
levels of muscle enzymes, an abnormal finding on
electromyography, and an abnormal finding on muscle
biopsy. The fifth criterion was compatible with cutaneous
disease.2
Recently, a scoring tool was proposed for muscle biopsy
evaluation in patients with juvenile dermatomyositis,
which was based on four domains of change:
inflammatory, vascular, muscle fiber, and connective
tissue. The inflammatory and muscle fiber domains had
the highest reliability and agreement.3
We report here a case of an adolescent female child
with muscle biopsy proven dermatomyositis.
CASE REPORT
The patient, a 14-year-old adolescent, was in her usual
state of health till 3 years of age when it was noticed that
she had difficulty in walking and running. Her milestones
otherwise had been achieved at appropriate ages,
while the child continued to have spikes of low grade
intermittent fevers. She was taken to various doctors
and had received treatment for about a year now, which
included various topical applications for the rash and
multi vitamin supplements for her stated 'weakness'.
Physical examination revealed an emaciated girl with
fever of 38.4°C. There was a discoid, erythematous,
violaceous rash involving the dorsum of her hands and
fingers. Bilateral depigmentation and dermal thickening
of her knuckles were present. A generalized erythema
involving the shoulders and the back was also present.
Joint and muscular system examinations revealed a
bilateral asymmetric involvement of the proximal
muscles of the lower limbs. She demonstrated difficulty
in standing from a sitting position and vice versa.
Gower's sign was hence found to be positive.
Examination of the upper limbs revealed permanent
contractures (Figure 1). Rest of the systemic exami-
nation was unremarkable.
Laboratory examination showed elevated creatine
kinase (337 mg/dl), lactate dehydrogenase (2229 mg/dl)
and aldolase (8.7 mg/dl), with normal levels of serum
aminoaspartate, serum alanine aspartate, C-reactive
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CASE REPORT
Figure 1:  A 14-year-old girl with characteristic rash and joint deformity.
 
protein and erythrocyte segmentation rate. Autoimmune
work up revealed a positive rheumatoid factor (RF), and
anti-nuclear antibody (ANA) with a homogenous pattern
(titres not available) with a negative anti-smith antibody,
anti-mitochondrial antibody and complement (C3, C4
and C1q) levels. Urinalysis results were within normal
limits.
Electromyography (EMG) was abnormal, with indications
of muscle irritability. It was reported to have short-
duration, low-amplitude, polyphasic units and increased
spontaneous activity with fibrillations, complex repetitive
discharges, and positive sharp waves with early
recruitment, highly consistent of a myopathic process.
Muscle biopsy was taken from vastus lateralis muscle.
The histopathology showed marked variation in the
size, with focal and perifascicular atrophy and loss
of muscle fibers. Scattered fibers showed splitting
and internalization. Dense, non-specific inflammatory
infiltrate was observed, pre-dominantly centred around
the vessels and hence was stated to be consistent with
a chronic inflammatory process, most likely dermato-
myositis. The raised alkaline phosphatase levels were
said to signify a primary muscle disease. Figures 2 (a-d)
detail the patient's skin and muscle biopsies.
There was marked clinical improvement after she was
started on prednisone and hydroxychloroquine therapy.
Her laboratory parameters from last follow-up have
been reported to be within the normal range. She is in
remission now. She is still on the same therapy, but on
maintenance doses.
DISCUSSION
Although dermatomyositis was first described in
1863, its course is so variable as to be difficult to predict.
In children the clinical pattern tends to be more
characteristic than in adults, in whom vascular lesions
have been less characteristic of the pathological
findings. The average age at diagnosis is 40 years and
almost twice as many women are affected as men.
Juvenile dermatomyositis (JDM), an important subtype
of dermatomyositis is a multisystem disease charac-
terized by inflammation of muscle, skin and gastro-
intestinal tract. In children, immune complex vasculitis of
various severity is the pathological hallmark. By
definition, the onset of JDM occurs in children younger
than 16 years of age, with girls being affected more than
boys.4
Dermatomyositis presents with characteristic cutaneous
and joint manifestations. These manifestations of
dermatomyositis are generally grouped as patho-
gnomonic, characteristic, compatible, less common and
rare.
Among the cutaneous findings, 'heliotrope', a macular
rash with periorbital edema, is considered a charac-
teristic finding of dermatomyositis, as are periungual
telangiectasias.5 The rash occurs early in the course of
the disease in 30 to 60 percent of patients.3 The
characteristic lesions of the shawl sign and the V-sign
appear as erythematous, poikilodermatous macules
distributed in a "shawl" pattern over the shoulders, arms
and upper back and in a V-shaped distribution over the
anterior neck and chest. Mechanic's hand may be
associated with an increased risk of interstitial lung
disease.6
The rash over the patient's hands was consistent with
Gottron's papules, the pathognomonic joint manifes-
tation of JDM, which by definition are violaceous
papules overlying the dorsal interphalangeal or meta-
carpophalangeal areas, elbow or knee joints, occur in
approximately 70% of patients with dermatomyositis.7
Patients may exhibit weakness of the truncal muscles
that requires them to use their arms to push themselves
up from a prone position i.e. Gower's sign. The sign was
present in this patient.
JDM usually can be diagnosed on a clinical basis in
children with a characteristic rash and proximal muscle
weakness. However, a complete history should be
obtained and a physical examination performed,
including a thorough review of systems, with an
emphasis on myositis-related presentations and
evidence of skin changes.
The routinely done laboratory work up includes creatine
kinase (CK), lactate dehydrogenase (LDH), aldolase,
and aspartate aminotransferase (AST) for the evaluation
Journal of the College of Physicians and Surgeons Pakistan  2011, Vol. 21 (7): 434-436 435
Juvenile dermatomyositis
Figure 2a: LCA immunostain
highlights the lymphocytes around
muscle fibers.
Figure 2b: Skeletal muscle tissue
(4X) with variation in fiber size and
hypereosinophilic fibers.
Figure 2c: Skeletal muscle (20X)
fascicles showing perifascicular
atrophy and lymphoid infiltrate.
Figure 2d: Skin biopsy (10X)
showing mild lymphocytic infiltrate
in the dermis.
of myopathy. Elevation in the serum concentration of
one or more of these enzymes occurs sometime in
nearly every patient.8
Muscle biopsy is the definitive test in establishing the
diagnosis of JPM or JDM and in excluding many other
causes of myopathy. The hallmark of histologic change
in JDM is the presence of a vasculopathy in skin,
muscle, and gastrointestinal tissue that progresses in
stages.9 In this patient, the diagnosis was based on the
muscle biopsy which suggested inflammatory changes
consistent with dermatomyositis.
The goal of the therapy is to improve function and
prevent disability. The treatment regimen must be
instituted early and requires a team approach between
the physical therapist, dermatologist and family
physician. Of the many therapeutic measures employed
at one time or another for juvenile dermatomyositis,
corticosteroids have received the most attention. In
those individuals with a good response to initial
glucocorticoid treatment, muscle enzymes should return
to normal in 6 to 12 weeks, followed by the return of
muscle strength. The use of IVIG in JDM has been
evaluated in several preliminary studies involving
children who had previously failed treatment with
glucocorticoids, and in most cases immunosuppressive
agents.10
Poor prognostic indicators in juvenile dermatomyositis
are late onset of treatment, initial treatment with a
dosage of prednisone that is too low, recalcitrant
disease and pharyngeal involvement.
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